| Disappearance of a syndrome: Dressler's syndrome in the era of thrombolysis. | |
| | |
MedLine Citation:
|
PMID: 7987883 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The incidence of the post-myocardial infarction syndrome (Dressler's syndrome) among thrombolized patients has not been established yet. To clarify this issue we prospectively studied 201 consecutive patients with acute myocardial infarction who had undergone recombinant tissue-type plasminogen activator therapy followed by 5 days of heparin administration. All patients were followed for at least 3 months for clinical signs of Dressler's syndrome. None of the 148 patients (76%) who showed clinical signs of early reperfusion had Dressler's syndrome. The sole patient in the group who manifested the syndrome developed it 3 weeks following extensive anterior myocardial infarction with no evidence of reperfusion. Although 4 patients manifested signs of early pericarditis, none developed the syndrome. We conclude that Dressler's syndrome has in fact been rendered a rare phenomenon among patients who benefit from thrombolytic therapy. |
| | |
Authors:
|
A Shahar; H Hod; G M Barabash; E Kaplinsky; M Motro |
Related Documents
:
|
743843 - Massive ankylosis following total hip anthroplasty. 21954533 - Our experience with mckusick-kaufman syndrome patients. 12455813 - Hematological manifestations of rheumatoid arthritis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Cardiology Volume: 85 ISSN: 0008-6312 ISO Abbreviation: Cardiology Publication Date: 1994 |
Date Detail:
|
Created Date: 1995-01-10 Completed Date: 1995-01-10 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 1266406 Medline TA: Cardiology Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 255-8 Citation Subset: IM |
Affiliation:
|
Emergency Department and Heart Institute, Sheba Medical Center, Tel-Hashomer, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Female Fever / etiology Humans Male Middle Aged Myocardial Infarction / complications*, drug therapy Pericardial Effusion / etiology Pericarditis / etiology* Pneumonia / etiology Syndrome Thrombolytic Therapy* Tissue Plasminogen Activator / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.21.68/Tissue Plasminogen Activator |
| Comments/Corrections | |
Comment In:
|
Cardiology. 1995;86(5):444
[PMID:
7585752
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate p...
Next Document: Ten-year mortality of patients admitted to coronary care units with and without myocardial infarctio...